Stroke Card Long-term Follow-Up
NCT04205006 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-08-30
Summary
We undertook the STROKE-CARD trial (NCT02156778) between 2014 and 2018 with follow-up until 2019 to evaluate the efficacy of the Post-Stroke disease-management program STROKE-CARD care. To further investigate the long-term efficacy of STROKE-CARD care all participants of the original trial will be invited for a Long-term in Person follow-up (3 - 6 years).
Conditions
- Ischemic Stroke
- TIA
Sponsors & Collaborators
-
VASCage GmbH
collaborator OTHER -
Tirol Kiniken GmbH
collaborator OTHER -
Barmherzige Brüder Vienna
collaborator OTHER -
Medical University Innsbruck
lead OTHER
Principal Investigators
-
Stefan Kiechl, Prof. Dr. · Medical University of Innsbruck, Austria, Department of Neurology
-
Wilfried Lang, Prof. Dr. · Hospital St. John's of God, Vienna, Austria, Department of Neurology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-16
- Primary Completion
- 2022-11-01
- Completion
- 2022-11-01
Countries
- Austria
Study Locations
More Related Trials
-
Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
NCT06853535 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
NCT04047563 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
NCT03021928 ·Status: UNKNOWN ·Phase: PHASE3
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke
NCT04733742 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke
NCT02611440 ·Status: UNKNOWN ·Phase: NA
-
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
NCT02002325 ·Status: UNKNOWN ·Phase: PHASE3
-
Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI)
NCT01264549 ·Status: COMPLETED ·Phase: NA
-
Carotid Endarterectomy Versus Stenting in Patients With Acute Stage of Ischemic Stroke.
NCT07083986 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
NCT05691244 ·Status: RECRUITING ·Phase: PHASE3
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
NCT02398656 ·Status: COMPLETED ·Phase: PHASE3
-
Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
NCT02953405 ·Status: UNKNOWN
-
Trial of a Secondary Stroke Prevention Program
NCT01071408 ·Status: COMPLETED ·Phase: NA
-
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
NCT06785740 ·Status: RECRUITING
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial
NCT07295366 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke)
NCT02607358 ·Status: COMPLETED
-
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT06320431 ·Status: RECRUITING ·Phase: PHASE3
-
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314 ·Status: RECRUITING ·Phase: NA
-
TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
NCT01654445 ·Status: COMPLETED ·Phase: PHASE2
-
A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
NCT04962503 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis
NCT03062319 ·Status: TERMINATED ·Phase: PHASE4